Do Wall Street Analysts Like STERIS Stock?

Ohio-based STERIS plc (STE) develops, manufactures, and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. Valued at a market cap of $21.3 billion, the company operates through three segments, which are Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. 

Shares of this healthcare company have underperformed the broader market over the past 52 weeks. STE has gained 8% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 31.8%. Moreover, on a YTD basis, the stock is down 1.2%, compared to SPX’s 25.8% gains.